Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1644 of 6351
-
New device aims to stop leakage without surgery
Disease control OngoingThe goal of this pivotal clinical trial is to evaluate the safety and effectiveness of the SUI-100 device for the treatment of mild-to-moderate stress urinary incontinence (SUI) in females aged 22-70 years. The main questions this study aims to answer are: 1. Does treatment wit…
Sponsor: Acoustic Wave Cell Therapy, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a common allergy drug help prevent C-Sections?
Disease control Recruiting nowThe purpose of this study is to is to determine the clinical effectiveness of a single dose of intravenous (IV) medication for the prevention of labor arrest and cesarean delivery in primiparous women undergoing trial of labor.
Phase 2/3 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New online program aims to boost stroke recovery and ease caregiver strain
Symptom relief Recruiting nowStroke is a leading cause of long-term disability. Research has placed little emphasis on integrating care partners (CP) (family members) into the rehabilitation process without increasing negative care partner outcomes. The research team has developed and implemented a novel, we…
Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New hope for advanced cancer? early trial tests MK-3120
Disease control Recruiting nowResearchers are looking for new ways to treat people with certain advanced solid tumors. Advanced means the cancer has spread to other parts of the body and cannot be removed with surgery. Solid tumors are cancers mostly in body organs and tissues, not in the blood or other body …
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Triple-Drug cocktail targets Hard-to-Treat colorectal cancer
Disease control OngoingThe goal of this study is to learn if a new combination treatment is effective for patients with microsatellite stable, advanced colorectal cancer. The study treatment combines 3 drugs: atezolizumab, bevacizumab, and tiragolumab. The main questions the study aims to answer are: …
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Pregnant women needed for yellow fever vaccine study
Vaccine Recruiting nowThe aim of this study is to compare the immunogenicity induced by yellow fever vaccination administered during pregnancy with that induced by vaccination outside pregnancy, and to assess the maternal and fetal tolerance of this vaccination.
Sponsor: Institut Pasteur • Aim: Vaccine
Last updated Jun 27, 2026 08:04 UTC
-
Could a cancer pill slow aggressive brain tumors?
Disease control Recruiting nowThis study is being done to learn about how an investigational drug called abemaciclib works in treating patients with a newly-diagnosed grade 3 meningioma. Abemaciclib is a drug that is approved by the FDA, but not for brain tumors. Participants who consent to the trial will ha…
Phase 2 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug targets Hard-to-Treat cancers with missing gene
Disease control Recruiting nowThis is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP loss. The first part of the study is an open-label, dose escalation and the second part is an open label dose expansion in…
Phase 1/2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
School-Based HPV vaccine push: 5,000 kids to test new education methods
Vaccine Recruiting nowThis study aims to evaluate the impact of active health education methodologies on increasing adherence to the HPV vaccine among schoolchildren. The project will involve 196 schools across Brazil, encompassing a total of 5,000 students. A stepped-wedge implementation design will…
Sponsor: Hospital Israelita Albert Einstein • Aim: Vaccine
Last updated Jun 27, 2026 07:57 UTC
-
New leukemia drug asciminib tracked in real-world saudi study
Disease control Recruiting nowThis is a non-interventional, prospective, observational single arm study describing the real-world effectiveness, tolerability, adherence, Healthcare Resource Utilization (HCRU) and Patient-Reported Outcome (PRO) data of asciminib in patients with Ph+ Chronic Myelogenous Leukemi…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Preschoolers get extra exercise and health lessons to fight obesity
Prevention OngoingThis study aimed to develop a comprehensive, multi-faceted intervention program for weight control and systematically evaluated its effectiveness on indicators of adiposity.
Sponsor: Soochow University • Aim: Prevention
Last updated Jul 29, 2026 00:00 UTC
-
Blood test may spot hidden skin cancer after surgery
Knowledge-focused Recruiting nowThe purpose of this study is to test the potential for a liquid biopsy assay to detect residual disease after surgery in patients with cutaneous squamous cell carcinoma as well as the potential for this assay to monitor response to immunotherapy treatment.
Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Engineered immune cells take on advanced skin and soft tissue cancers
Disease control Recruiting nowA single center, dose escalaion, Phase I clinical trial to demonstrate safety and efficacy of LauT-1, autologous "New York Esophageal Squamous Cell Carcinoma-1 T-Cell Receptor (NY-ESO-1 TCR)-directed T cells in combination with non-myeloablative (NMA) lymphodepleting chemotherapy…
Phase 1 • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Experimental drug ACT001 targets tough brain tumors in small trial
Disease control Recruiting nowThis trial will study the effectiveness of ACT001 in adult patients whose Glioblastoma have recurred with a STAT3-high signature after standard-of-care treatment with at least radiation therapy.
Phase 2 • Sponsor: National Neuroscience Institute • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Brain zaps may cut pneumonia risk after stroke
Disease control Recruiting nowBACKGROUND: Dysphagia is one of the most life-threatening stroke complications. Dysphagic stroke patients are at increased risk of aspiration pneumonia. Pneumonia accounts for at least 10% of post stroke deaths within 30 days of hospitalization after stroke. rTMS is effective in …
Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
One lung or two? surgery trial aims to find the best approach for severe COPD
Disease control Recruiting nowThis study compares two surgical approaches for patients with severe Chronic Obstructive Pulmonary Disease (COPD) and severe emphysema: unilateral (operating on one lung) versus bilateral (operating on both lungs) lung volume reduction surgery (LVRS).
Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a tweaked stomach surgery stop reflux? new trial aims to find out
Disease control Recruiting nowThis is a two-site randomized clinical trial aiming to test whether a modified investigational bariatric surgical procedure can improve gastroesophageal reflux disease (GERD) after sleeve gastrectomy.
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a scaffold help nerves regrow? new trial launches
Disease control Recruiting nowThis is a multicenter, prospective, randomized, subject and evaluator blinded clinical trial to asses the efficacy of Auxilium's NeuroSpan Bridge.
Sponsor: Auxilium Biotechnologies • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Cold virus turned cancer killer enters human trials
Disease control Recruiting nowATTR-01 is the experimental drug being studied in the ATTEST clinical trial. The drug is made from a common cold virus that has been changed to only infect and multiply in cancer cells. This virus delivers an immune therapy drug into the cancer that is intended to promote a parti…
Phase 1/2 • Sponsor: Accession Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Promising drug may ease painful genital psoriasis
Symptom relief OngoingPhase 3 study to evaluate the efficacy and safety of subcutaneous Tildrakizumab in subjects with moderate to severe genital psoriasis.
Phase 3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC